longevitywatch
← Back
Research
Sleep

Melatonin shields the liver from alcohol damage

Chronic alcohol use damages the liver in multiple ways at once. Melatonin, best known as a sleep hormone, appears to block several of those damage pathways simultaneously.

LongevityWatch editorsJune 5, 2026

Alcoholic fatty liver disease (AFLD) is one of the most common liver conditions worldwide. Chronic alcohol consumption causes fat to accumulate in the liver, damages cells through oxidative stress (harm caused by free radicals), and triggers inflammation. Left untreated, this can progress to cirrhosis or liver cancer.

Melatonin is widely recognised as a sleep regulator, but it also has strong antioxidant properties. The study, conducted in a mouse model of AFLD and published in Frontiers in Veterinary Science, examined which biological pathways melatonin protects against.

Multiple protective mechanisms

The researchers found that melatonin reduced fat accumulation in the liver. Activity in inflammation-promoting signalling pathways also declined. Melatonin additionally protected mitochondria (the energy-producing structures in cells) from alcohol-related damage. This matters because mitochondrial dysfunction plays a central role in liver aging and liver disease.

The mechanism appears to work through a reduction in oxidative stress within liver cells. Melatonin neutralises free radicals and simultaneously raises the production of protective enzymes inside the cell.

Interpreting with caution

This study was conducted in mice. The results cannot be directly extrapolated to humans. Melatonin supplements are commercially available, but the doses used in this research far exceed those found in standard supplements. Melatonin is also not primarily intended as a liver-protective agent.

Even so, the study is relevant for understanding how oxidative stress amplifies liver damage. Whether antioxidant interventions can play a role in protecting the aging liver remains an active area of research.

Read the original article

ShareX / TwitterLinkedIn